Enterococcus faecium

Vancomycin-resistant Enterococcus faecium (VREF) causes an infection common in US hospitals and is resistant to all commercially available antibiotics. Hospital outbreaks are rare in Europe, although VREF carriage among healthy individuals and livestock is common. A study from the National Institute of Public Health, Bilthoven, Netherlands, published in the online version of the Lancet on 13 March, suggests that genetic screening of E. faecium carriers could help eradicate this infection (Lancet

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Vancomycin-resistant Enterococcus faecium (VREF) causes an infection common in US hospitals and is resistant to all commercially available antibiotics. Hospital outbreaks are rare in Europe, although VREF carriage among healthy individuals and livestock is common. A study from the National Institute of Public Health, Bilthoven, Netherlands, published in the online version of the Lancet on 13 March, suggests that genetic screening of E. faecium carriers could help eradicate this infection (Lancet 2001, 357:853-854).

Willems et al used DNA probes based on the esp virulence gene from E. faecalis, and screened (by Southern blotting) chromosomal digests of 120 VREF isolates associated with hospital outbreaks in the US, Europe and Australia. These were compared with 45 non-epidemic isolates. A particular subpopulation of E. faecium was associated with epidemic outbreaks in all three continents, and these epidemic strains carried a variant of the esp gene. The variant was not present in non-epidemic and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours